The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical and molecular outcomes of gastrointestinal malignancies treated with early phase studies: A retrospective single-center experience.
 
Tarik Demir
No Relationships to Disclose
 
Nicole Altomare
No Relationships to Disclose
 
Katrina Dobinda
No Relationships to Disclose
 
Ruohui Chen
No Relationships to Disclose
 
Carolyn Moloney
No Relationships to Disclose
 
Aparna Kalyan
No Relationships to Disclose
 
Mary Mulcahy
No Relationships to Disclose
 
Sheetal Kircher
Stock and Other Ownership Interests - Abbott/AbbVie
 
Al Benson III
Consulting or Advisory Role - Abbvie; Amgen Astellas BioPharma; Apexigen; Array BioPharma; Artemida Pharma; Boehringer Ingelheim; Boston Scientific; Bristol Myers Squibb Foundation; Bristol-Myers Squibb; GlaxoSmithKline; HalioDx; Hutchmed; Janssen Oncology; Merck Sharp & Dohme; Mirati Therapeutics; Natera; Novartis/Pfizer; Pfizer; Pfizer; Samsung Bioepis; Therabionic; Xencor
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Elevar Therapeutics (Inst); Infinity Pharmaceuticals (Inst); ITM Solucin (Inst); MedImmune (Inst); Merck Sharp & Dohme (Inst); Rafael Pharmaceuticals (Inst); st pharm (Inst); SynCoreBio (Inst); Taiho Pharmaceutical (Inst); Tyme Inc (Inst); Xencor (Inst)
 
Devalingam Mahalingam
No Relationships to Disclose